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Introduction
Muscular dystrophies (MDs) are genetic diseases 
characterized by progressive skeletal muscle 
weakness and degeneration. There are many kinds 
of MDs with a wide variability in term of age 
at onset and degree of disability (Davies and 
Nowak, 2006), due to mutations in different genes. 
The mechanisms underlying the skeletal muscle 
failure are complex and involve several biological 
pathways, including oxidative stress. Oxidative 
stress is a disturbance in the balance between the 
production of reactive oxygen/nitrogen species 
(ROS/RNS) and the ability to detoxify them 
through the antioxidant defenses (Pisoschi et al., 
2015). The effect of oxidative stress on muscle 
damage inducted by physical exercise is widely 
debated. To date, physical exercise is considered 
to be a major component of a healthy lifestyle 
since it prevents several chronic diseases such 
as osteoporosis, diabetes, cancer, hypertension, 
obesity, depression, and cardiovascular disease 
(Gomez-Cabrera et al., 2008). Nevertheless, the 
relationship between exercise and oxidative stress 
is extremely complex, depending on the mode, 
intensity, and duration of exercise. While an acute 
and strenuous exercise can generate an excess of 
free radicals production, a regular and moderate 
exercise seems to counteract oxidative stress-
related damage. These conflicting effects may be 
explained by the hormesis theory, according to 
which a substance, that is detrimental at high doses, 
induces an adaptive response that carriers out 
beneficial effects on the cells (Boccatonda et al., 
2016). However, despite these evidences, the topic 
of exercise-induced oxidative stress is still unclear.
In this review we will discuss: (i) the mechanisms 
of ROS/RNS production in the skeletal muscle and 
the involvement of oxidative stress in muscular 
dystrophies (MDs), focusing on Duchenne/Becker 
muscular dystrophy, myotonic dystrophy type 1, 
facioscapolohumeral muscular dystrophy and limb-
girdle muscular dystrophies, (ii) if exercise training can 
be helpful to reduce oxidative stress and fatigue in MDs.
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ROS/RNS production in skeletal muscle
ROS/RNS include molecules such as superoxide 
anion (O
2
–), hydrogen peroxide (H
2
O
2
), hydroxyl 
radicals (OH·), nitric oxide (NO·), nitrogen dioxide 
(NO
2
) and peroxynitrite (ONOO–) (Giorgio et al., 
2007; Schieber and Chandel 2014; Kurutas, 2016).
Primary sources of ROS in muscle cells are, the 
electron transport chain (ETC) in the mitochondria, 
the NADPH oxidase (Nox), the xanthine oxidase 
(XO) and the phospholipase A2 (PLA2) (Halliwell 
2007; Pwers and Jackson 2008; Steinbacher and 
Eckl 2015) (Figure 1).
ROS production across the ETC is a consequence of 
the inefficiencies in the transfer of electrons among 
its complexes (primarily complex I and complex III): 
when electrons escape from the complexes before 
the reduction of molecular oxygen (O
2
) to water 
(H
2
O), they react with O
2
 forming O
2
– (Brand et al., 
2010). ROS production in the mitochondria of muscle 
cells is approximately 0.15%, smaller than expected 
(1%–4%) (Steinbacher and Eckl, 2015). In a recent 
study, Goncalves and co-workers (2015) use new 
approaches (an ex vivo system) to evaluate, from 
muscle tissue, different production sites of O
2
–/H
2
O
2
 
in the mitochondrion during rest, mild, and intense 
aerobic exercise. The authors provide the first evidence 
that not only complex I (site IF) and complex III (site 
IIIQo), but also sites IQ and IIF (in complex II) should 
be considered for ROS production. In particular, at 
rest O
2
– and H
2
O
2
 are predominantly produced from 
IQ and IIF sites, followed by sites IF and IIIQo. 
Under conditions that mimic mild and intense aerobic 
exercise, total ROS production is reduced.
To a greater extent than mitochondria, Nox enzymes 
contribute to cytosolic O
2
– production in skeletal 
muscle both at rest and during contractile activity. 
Nox include a family of protein consisting of 
seven members: Nox1-Nox5, Duox1-Duox-2 each 
of which shows distinct tissue-specific expression 
patterns (e.g. Nox1 is expressed in the smooth 
muscle, while Nox2 is expressed in skeletal muscle, 
and neurons) (Pendyala and Natarajan, 2010).
XO can be a large source of free radicals production 
since it utilizes hypoxanthine or xanthine as substrate 
and O
2
 as cofactor to produce O
2
 – and uric acid 
(Chung et al., 1997; Ryan et al., 2011). Upon 
contraction, XO activity is significantly increased 
leading to oxidative stress and muscle damage 
(Steinbacher and Eckl, 2015).
PLA2 contributes to elevation of ROS in skeletal 
muscle by catalyzing production of arachidonic 
acid by ROS-producing lipoxygenases, promoting 
the translocation of Nox to the sarcolemma, and 
increasing ROS production in mitochondria (Choi 
et al., 2016).
Between RNS, NO· is a low-reactive molecule 
involved in several cellular mechanisms such 
as the regulation of the vasomotor tone and of 
immunomodulatory signaling pathways (Mangge 
et al., 2014) and neuronal activity (Pacher et al., 
2007). NO· is rapidly removed by the conversion 
to nitrite/nitrate, limiting its biological half-life 
(Pacher et al., 2007). Only in presence of O
2
–, 
NO· can becomes toxic forming the much more 
powerful oxidant ONOO– (Pacher et al., 2007; 
Mangge et al., 2014). NO· is synthesized by the 
nitric oxide synthase (NOS) enzyme that converts 
L-arginine into L-citrulline, utilizing NADPH and 
O
2
 as co-factors (Choi et al., 2016). NOSs are 
enzymes that includes different isoforms: neuronal 
NOS (nNOS or NOS1), inducible NOS (iNOS or 
NOS2) and endothelial NOS (eNOS or NOS3) 
(Powers and Jackson, 2008). In skeletal muscle 
nNOS, localized both in cytoplasm and sarcolemma, 
is considered the primary source of RNS. NO· is 
mainly synthesizes by nNOS splice variant mu 
(nNOSµ). The nNOSµ localization and activity are 
regulated by interaction between proteins as well 
as by translational modifications. nNOSµ and NO· 
regulate hypertrophy, fiber type, force production 
(excitation-contraction coupling), fatigue resistance, 
microtubule organization, regulation of blood flow, 
myocyte differentiation, respiration, and glucose 
homeostasis (Stamler and Meissner, 2001), but 
the mechanisms underlying these functions are 
still unknown. NO· activates soluble guanylyl 
cyclases (GCs) generating guanosine 3’,5’-cyclic 
monophosphate (cGMP); intracellular increase of the 
cGMP levels may further activate cGMP-dependent 
protein kinase (PKG) (Wang and Robinson, 1997). 
In mouse models, nNOS activity can be significantly 
increased by regular physical exercise and aerobic 
training activating the NO/GCs/cGMP pathway. 
Conversely, down-regulation of NO production 
increases exercise metabolic cost and decreases 
running performance (Chalimoniuk et al., 2015).
Increased ROS/RNS levels induce damage to 
nucleic acids, lipids, and proteins that can leads to 
 PHYSICAL EXERCISE AND OXIDATIVE STRESS IN MUSCULAR DYSTROPHIES: IS THERE A GOOD BALANCE? 13
cellular death by apoptotic mechanisms. Much of 
the evidences in this field have been made possible 
analyzing changes in several oxidative stress markers. 
In fact, lipid peroxidation leads to alterations in the 
degree of membranes fluidity, deficit of membrane-
bound receptors and enzymes; moreover it may 
contribute to amplify cellular damage resulting 
from generation of oxidized products. Several 
products of lipid peroxidation are usually used 
as biomarkers of oxidative/nitrosative stress, such 
as malondialdehyde (MDA), 4-hydroxy-2-nonenal 
(HNE), 2-propenal, isoprostanes (F2-IsoPs) and 
thiobarbituric acid reactive substances (TBARS) 
(Kurutas, 2016; Cipak Gasparovic et al., 2016).
NOO– causes post-translational modifications of 
proteins, inducing nitrative stress which results in an 
increase of tyrosine nitration (3-nitrotyrosine, 3-NT) 
levels. Other biomarkers for protein-oxidative damage 
include: protein carbonyls, advanced lipoxidation end 
products, advanced glycation end products (AGEs), 
oxidized low-density lipoprotein (oxLDL), thought 
the utility of this biomarker has been criticized 
(Frijhoff et al., 2015), and advanced oxidation protein 
products (AOPP) (Bouzid et al., 2015).
It is also found that ROS induce damage to DNA 
and RNA; the two major biomarkers used to test any 
alterations in these biomolecules are 7,8-dihydro-8-
oxo-2c-deoxyguanosine (8oxodG) and 7,8-dihydro-
8-oxoguanosine (8oxoGuo), respectively (Frijhoff 
et al., 2015).
Antioxidant compounds
Humans have developed complex antioxidant systems, 
both enzymatic and non-enzymatic, which act in 
synergy to prevent or reduce the oxidative damage 
(Kurutas, 2016). Among the enzymatic molecules, 
play a primary role, superoxide dismutase (SOD), 
that exist in three isoforms (SOD1- SOD3), catalase 
(CAT), glutathione peroxidase (with five isoforms 
Fig. 1. - Primary sources of ROS in muscle cells. Abbreviations. ETC: electron transport chain Nox: NADPH oxidase, 
XO: xanthine oxidase, PLA2: phospholipase A2, O2
–: superoxide anion, H2O2: hydrogen peroxide, OH·: hydroxyl 
radicals, NO·: nitric oxide, ONOO–: peroxynitrite, SOD: superoxide dismutase, CAT: catalase, GSH: glutathione, GR: 
glutathione reductase, GPX: glutathione peroxidase, O2: oxygen, H2O: water, GSH: reduced glutathione, GSSG: 
oxidized glutathione, PRX: peroxiredoxina, AA: arachidonic acid.
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GPX1-GPX5) and glutathione reductase (GR). SOD 
dismutates O
2
– to form H
2
O
2
 and oxygen (O
2
), CAT 
catalyses conversion of H
2
O
2
 into O
2 
and water 
(H
2
O). GPXs reduce H
2
O
2
 or organic hydroperoxide 
(ROOH) into H
2
O and alcohol (ROH), respectively, 
using reduced glutathione (GSH). This one can be 
oxidized to glutathione disulfide (GSSG) that can be 
reduced again to GSH by GR enzyme.
In addition to these antioxidants, there are other 
enzymes, such as thioredoxin, thioredoxin reductase, 
glutaredoxin, and peroxiredoxin that can be useful to 
maintain the redox balance (Powers and Jackson 
2008) (Figure 1).
Between endogenous non-enzymatic antioxidants 
play a major role the thiol compounds like 
glutathione, lipoic acid and thioredoxins, which 
contain a sulphydryl group important to scavenger 
ROS. Also other proteins like ferritin, transferrin, 
ceruloplasmin, albuminuric acid, and coenzyme Q 
(CoQ10), are part of this “class” of antioxidants 
(Pisoschi et al., 2015).
However, under certain conditions that sustain ROS/
RNS production, endogenous antioxidants may not 
be sufficient to limit oxidative damage, and the 
addition of dietary antioxidants, such as vitamin C, 
vitamin E, melatonin, carotenoids, and flavonoids 
may be used to maintain optimal cellular functions 
(Pisoschi et al., 2015; Kurutas, 2016).
A reduction of antioxidant enzymes (SOD, CAT, 
GPX, GR) activity and of GSH/GSSG ratio was 
found in oxidative stress conditions. Also several 
antioxidant capacity assays have been used among 
which Trolox Equivalent Antioxidant Capacity 
(TEAC), Total Antioxidant Status (TAS), Ferric 
Reducing Ability of Plasma (FRAP), Total Radical - 
Trapping Antioxidant Parameter (TRAP), and Oxygen 
Radical Absorbance Capacity (ORAC) (Powers and 
Jackson, 2008; Fisher-Wellman and Bloomer 2009).
Evidences of oxidative stress 
involvement in MDs
Oxidative stress in Duchenne muscular 
dystrophy and Becker muscular dystrophy
Among MDs, Duchenne muscular dystrophy 
(DMD) is the most frequent disorder in children; 
it is a severe and progressive disease that affects 
approximately 1/3500 male births. Becker muscular 
dystrophy (BMD) is a milder variant of DMD in 
which symptoms appearing later in childhood or 
in adolescence (Darras et al., 2000; Dahlqvist and 
Vissing 2016). DMD and BMD are caused by 
mutations in the dystrophin gene that encodes for 
a protein which is a member of the dystrophin-
associated glycoprotein (DAG) complex. It connects 
the contractile components within the myofiber to 
the extracellular matrix and helps to stabilize the 
sarcolemma (Ervasti and Campbell, 1991). Patients 
with DMD have a complete loss of dystrophin, while 
patients with BMD show a reduction of dystrophin 
at muscle level (Dahlqvist and Vissing, 2016).
The mdx mouse that harbors a point mutation in 
the dystrophin gene has been widely studied as 
a mouse model for DMD. Numerous evidences, 
both in mdx mouse and humans, underline the 
involvement of oxidative stress in the pathogenesis 
of DMD. The absence of dystrophin appears to 
render muscle more susceptible to oxidative damage. 
In that regard, using myotube cultures derived 
from normal and mdx mice, Rando et al. (1998) 
examined the susceptibility of the cells to different 
stressors, both pro-oxidants and non-oxidants, 
at different concentrations. The first compounds 
included H2O2, manadione (an inductor of several 
reactive species), and paraquat (it generates O
2
–). 
Non-oxidant stressors used were staurosporine (a 
pro-apoptotic compound), A23187 (an activator 
of proteases and an inducer of Ca2+), carbonyl 
cyanide m-chlorophenylhydrazone (an inhibitor of 
mitochondrial respiration). Cells derived from mdx 
muscles were more susceptible to pro-oxidants than 
normal myoblasts, but both cells populations were 
equally susceptible to non-antioxidant stressors. 
Probably, these responses were relative to dystrophin 
expression; indeed, undifferentiated myoblasts, that 
lacked in dystrophin, derived both from mdx and 
normal mice were equally sensitive to pro-oxidants 
supporting the hypothesis that oxidative stress may 
lead to myofiber death in DMD.
Moreover, studies showed significantly higher 
TBARS content, while SOD1 activity was decreased, 
while SOD2 and CAT activities were elevated in 
mdx mice muscles with respect to controls (Ragusa 
et al., 1997), and ectopic expression of CAT in 
mitochondria increased lifespan and led to a partial 
restoration of mdx muscle function (Selsby, 2011). 
Similar results have been found in humans in 
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which the levels of TBAR and the CAT and GR 
activities were significantly higher in muscles from 
DMD patients versus control subjects, while SOD 
activity was not altered in dystrophic muscles (Kar 
and Pearson, 1979). Also 8-OHdG was found to be 
elevated in DMD patients versus healthy controls 
(Rodriguez and Tarnopolsky, 2003).
The exact contribution of NO∙ in DMD pathogenesis 
is still unclear. This “gray zone” results from the 
secondary loss of the complex of proteins that 
interact with dystrophin, the so called dystrophin-
associated protein complex (DPC). Considering that 
nNOS is a member of the DPC, it is possible that 
the loss of nNOS from muscle cells contributes to 
the dystrophic pathology (Wehling et al., 2001). A 
lower NO production in dystrophic muscle could 
have harmful effects on muscle function because 
NO is involved in regulating several key processes 
in skeletal muscle (Tidball and Wehling-Henricks, 
2004). Grazdenovic et al. (1997) found (by enzyme 
immunochemistry and immunohistochemistry) that 
in DPC not only dystrophin, but also nNOS was 
absent in biopsies from DMD patients. In muscle 
tissue of BMD patients, similarly to dystrophin, 
nNOS expression was only reduced. Afterwards, 
Gücüyener and coworkers (Gücüyener et al., 2000) 
found that serum NOx levels were significantly lower 
in DMD than those of the controls. Nevertheless, 
other investigators observed that prenecrotic mdx 
muscle fibers did not exhibit changes in ∙NO-induced 
nitrotyrosine formation. Moreover, NOS-null mice 
did not develop dystrophic symptoms, and neither 
NOS-null nor mdx mice with ectopic NOS expression 
show any alteration in oxidative stress susceptibility 
(Rando et al., 2001). As reviewed by Heydemann 
and McNally (2009) nNOS null mice showed no 
feature of the MyDs, such as muscle degeneration. 
Moreover, the phenotype of nNOS and dystrophin 
double knockout mice was similar to that observed 
in the mdx model.
Oxidative stress in myotonic dystrophies
Myotonic dystrophy (MyD) is the most common 
form of muscular dystrophy that begins in adulthood, 
although there is a variant, called congenital 
MyD, that is apparent at birth. It is multisystemic 
disease, transmitted as autosomal dominant trait, 
characterized by a involvement of skeletal muscle 
and heart, but also eye, brain and endocrine system. 
The most frequent form of MyD, the type 1 (DM1), 
is characterized by nucleotide triplet expansions 
[(CTG)n] in the 3’-untranslated region of the 
myotonic dystrophy protein kinase (DMPK) gene, 
underlying to the complexity and multisystemic 
phenotypic variants of disease (Pantic et al., 2013).
The increased levels of ROS as well as a reduction of 
antioxidants is well documented in DM1, oxidative 
stress may be associated with muscular and extra-
muscular signs of the disease (Nikolic´-Kokic´ et al., 
2016). Previous in vitro studies (Usuki and Ishiura, 
1998) suggested the involvement of oxidative stress 
in the disease pathogenesis. For example, the effects 
of oxidative stress, inducted by methylmercury, 
on myogenic cells with expanded CTG repeats in 
the myotonin protein kinase (MtPK) gene were 
investigated. Mutant MtPK cDNA transformants 
(from 46 to 160 CTG repeats) treated with 
methylmercury (1 µM for 24 h) showed cell death, 
while in wild type MtPK cDNA transformants the 
toxicity and cell death were reduced In mutant 
transformants, the administration of N-acetyl-L-
cysteine and trolox (two antioxidants) suppressed the 
injury inducted by methylmercury. These findings 
emphasized the key role of ROS to evoke cellular 
damage which was amplified by expanded CTG 
repeats in MtPK.
Also human studies have been conducted to analyze 
the role of oxidative stress in DM1. In our study 
(Siciliano et al., 2005) we reported that plasma 
AOPP levels, total serum g-glutamyltransferase 
(GGT) activity (a crucial enzyme in modulating 
GSH), and GGT activity associated with low-density 
lipoprotein were significantly increased in DM1 
patients (N=38) with respect to controls (N=10). 
Moreover, raised AOPP levels correlated with extra-
muscular signs of the disease (cataracts and heart) 
but not with muscular involvement. Kumar et al. 
(Kumar et al., 2014) found significantly higher 
levels of MDA, and lower levels of GPX, GST and 
GSH in DM1 patients (N=20) with respect to control 
subjects (N=40), although SOD and TAS levels 
were increased in DM1 patients. In another recent 
study (Nikolic´-Kokic´ et al., 2016), the activities of 
erythrocyte SOD and CAT were reduced in DM1 
patients (N=30) versus controls (N=15). Moreover, 
a positive correlation was found between disease 
duration and muscular impairment rating scale 
score as well as with GR activity suggesting that 
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reductions in antioxidant enzyme activities during 
DM1 disease progression trigger oxidative stress 
and metabolic abnormalities that could contribute to 
muscle atrophy.
Oxidative stress in facioscapulohumeral 
muscular dystrophy
Facioscapulohumeral muscular dystrophy (FSHD), 
the third most prevalent hereditary myopathy 
in adulthood, is characterized by progressive, 
asymmetric atrophy and weakness of a selective 
muscle groups. Age of onset is variable, but in 
the classical form the majority of patients become 
symptomatic in the second-third decade. FSHD has 
been associated with a reduced number of 3.3 kb 
repeat units, called D4Z4, localized on chromosome 
4q35 (Ricci et al., 2013). A wide inter- and intra-
familial variability of clinical expression is well 
documented, without a clear correlation between the 
clinical phenotype and molecular variations (Ricci et 
al., 2013). To date, despite the identification of the 
molecular defect, its pathologic effects remain largely 
unknown (Ricci et al., 2014) Epigenetic mechanisms 
and/or loci modifications are supposed to be involved 
in modulating the incomplete penetrance and in 
influencing the disease expression (Lemmers et al., 
2015). It has been proposed that the reduction of the 
D4Z4 array results in the transcription of a double-
homeobox transcription factor, DUX4, encoded by 
an open reading frame in D4Z4 repeat. Although 
DUX4 mRNAs and proteins are extremely low, it 
has been observed that the DUX4-expressing FSHD 
muscle nuclei show pathologic features consistent 
with DUX4 induced toxicity (Gatica and Rosa, 
2016). According to the current pathogenic model of 
FSHD, epigenetic modifications, either related to the 
contraction of the array or to its hypomethylation, 
may result in the occasional escape from repression 
in muscle cells with a consequently inappropriate 
expression of DUX4 protein (Ricci et al., 2014). The 
overexpression of DUX4 is supposed to induce a 
gene deregulation cascade, including a deregulation 
in the oxidative stress response. The study of 
Turki et al. (2012) reported in muscle specimen of 
FSHD patients a higher oxidative stress damage, 
in term of lipid peroxidation, protein carbonylation 
and lipofuscin accumulation, in association with 
an abnormal mitochondrial function, decreased 
cytochrome c oxidase activity and reduced ATP 
synthesis. Recently, Dmitriev and coworkers 
(2016) provided evidence of oxidative DNA 
damage in vitro study using myoblasts isolated 
from FSHD patients. The authors reported that 
the addition of tempol, a powerful antioxidant, 
to the proliferating DUX4-transfected myoblasts 
and FSHD myoblasts, reduced the level of DNA 
damage. Notably, antioxidant treatment during 
the myogenic differentiation of FSHD myoblasts, 
significantly reduced morphological defects in 
myotube formation.
Oxidative stress in limb-girdle 
muscular dystrophies
Another group of MyDs clinically similar to DMD/
BMD is represented by the limb-girdle muscular 
dystrophies (LGMD). LGMD is a descriptive term 
that comprises different diseases with variable 
clinical expression, ranging from severe to mild 
forms, transmitted as an autosomal recessive or 
dominant trait (Darras et al., 2000), beginning 
in childhood or adulthood. The various forms of 
LGMD are caused by mutations in different genes 
that encode a wide variety of proteins, including 
components of the DAG complex, cytoplasmic 
enzymes, membrane and nuclear matrix proteins. 
The pathogenesis of LGMD involves different 
mechanisms such as increment of intracellular Ca2+ 
ions, infiltration of muscle tissue by inflammatory 
immune cells, enhancement of pro-inflammatory 
and profibrogenic cytokines, activation of 
proteolytic enzymes, defective autophagy, apoptosis 
and oxidative stress (Shin et al., 2013). It will be 
mentioned three types of LGMD as models of 
the possible oxidative stress involvement in their 
pathogenesis.
Among these muscle disorders, calpainopathy or 
LGMD2A is the most common form of autosomal 
recessive LGMD, due to the absence or reduction 
of the enzyme calpain 3, a non lysosomal calcium 
dependent cysteine protease. However, the function 
of calpain 3 in the muscle and the pathomechanisms 
of LGMD2A are not to date fully defined. Previous 
studies in calpainopathy mice have documented 
that oxidative stress occurs in LGMD2A, with the 
involvement of NF-kB pathway. Oxidative stress 
and NF-kB/IKK b signaling were also observed 
increase in muscle of LGMD2A patients, as 
potential contributor to protein ubiquitinylation and 
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muscle protein loss (Rajakumar et al., 2013). NF-κB 
and the ubiquitin pathways were also studied in 
muscle of patients affected by an other common 
form of recessive LGMD, the LGMD2B, due to 
dysferlin mutations, and in dysferlin knockdown 
human myoblasts and myotubes (Rajakumar et 
al., 2014). It was observed that in response to 
oxidative stress dysferlinopathic muscle biopsies 
showed protein ubiquitinylation induced by NF-κB 
p65 signaling. Moreover, investigations on dysferlin 
knockdown primary muscle cell cultures indicated 
that oxidative stress was induced in the absence 
of dysferlin. At muscle level, dysferlin is involved 
in plasma membrane repair, vesicle fusion and 
membrane trafficking. Subjects with mutations in 
the dysferlin gene can have impaired membrane 
resealing after mechanical or chemical stimuli, with 
consequent influx of Ca2+. Since mitochondria are 
responsible for Ca2+ buffering, mitochondrial defects 
with respiratory chain deficiency in muscle from 
patients with dysferlinopathies has been recently 
documented (Vincent et al., 2016).
Another form of autosomal dominat LGMD is the 
type 1B, due to mutations in LMNA gene that 
encodes lamin A/C, located at the nuclear envelope. In 
fibroblasts, myoblasts and muscle tissue of LGMD1 
patients nuclear abnormalities are well documented, 
consisting of alteration of nuclear lamina and loss 
of heterochromatin. There are evidence points to a 
relationship between LMNA mutation and altered 
redox homeostasis. In fact, a dysfunctional lamina 
can modulate ROS metabolism, since the nuclear 
envelope is a docking site for transcription factors and 
chromatin-associated proteins. Moreover, ROS can 
damage the nuclear envelope, contributing to cellular 
senescence and vulnerability to oxidative stress. The 
effects of ROS consist of steady DNA damage and 
telomere shortening, that are the mechanisms also 
involved in pathogenesis of laminopathies (Lattanzi 
et al., 2012; Sieprath et al., 2015).
Role of physical exercise in MDs
In the past, a common opinion was that, in subjects 
with muscle wasting, physical activity can accelerate 
muscle degeneration mechanisms. Repeated muscle 
contractions can reduce the strength limiting exercise 
performance which could result in muscle fatigue 
mainly due to lactic acidosis, as observed in MDs 
(Allen et al., 2008). However, other reports have 
highlighted that in humans undergoing exercise 
at different intensities, lactic acid does not have 
deleterious effects and does not induce muscle 
fatigue (Reid, 2008). Muscle fibers generate ROS 
at low levels that increase during exercise inducing 
muscle fatigue (Kuwahara et al., 2010) and increasing 
muscle atrophy (Steinbacher and Eckl, 2015). Many 
other mechanisms are implicate in muscle fatigue 
like changes in Ca2+ homeostasis, disruption of 
creatine phosphate as consequence of increased 
levels of inorganic phosphate ions, depletion of 
inter- and intramyofibrillar glycogen and increased 
levels of ROS in the myoplasm (Allen et al., 2008).
Nevertheless, considering that to date there is no 
curative treatment for most MDs, exercise training 
as treatment for these diseases, is receiving much 
attention. It follows from the evidence that the 
exercise conducted properly can help to maintain and 
improve health reducing the risk of several disorders 
(Dahlqvist and Vissing, 2016). However, dystrophic 
muscle fibers are known to be more susceptible to 
oxidative muscle damage after exercise, hence the 
need to understand how the muscle cells adapt to 
changes during physical activity, and if muscle from 
dystrophic patients are subjected to different coping 
mechanisms than those observed in control muscles 
(Schill et al., 2016).
Oxidative stress and physical exercise
Acute bouts of contractile exercises induced, in 
animal models, an increase of lipid hydroperoxides, 
4-HNE, protein carbonyls levels and a reduction 
in total glutathione levels, as well as increased XO 
activity (Judge and Dodd, 2003). Interestingly, 
well-trained humans and rats may be resistant to 
sudden increases of ROS levels caused by acute 
and strenuous exercise (Pingitore et al., 2015). In 
a study conducted by Oztasan and collaborators 
(Oztasan et al., 2004), acute exhausting exercise 
decreased erythrocyte MDA levels, and increased 
the erythrocyte SOD activity in trained (n=28) rats 
with respect to sedentary (n=26) rats. On the other 
hand, the erythrocyte GPX activity was increased 
in sedentary rats, thought, trained rats showed no 
variations in the enzyme activity.
Çakır-Atabek et al. (2015) found that that lower 
exercise intensity (50%) was sufficient to increase 
MDA levels, while only higher intensity (more 
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than 80%) was needed to induce an increase 
in carbonyl protein levels in trained (N=8) and 
untrained (N=8) men. MDA, protein carbonyl, and 
SOD concentrations significantly increased during 
exercise in trained, though MDA levels decreased 
during recovery and 24 h post-exercise. Instead, 
8-OHdG and GSH values did not significantly 
change during the test, while GSH levels were 
higher in trained men with respect to sedentary 
subjects. The beneficial effects of regular and non-
exhaustive physical activity are well known. Trained 
persons show higher levels of adaptation and less 
health risks. During regular exercise, ROS increase 
the antioxidant activity, mitochondrial biogenesis, 
cytoprotection and aerobic capacity of skeletal 
muscle (Steinbacher and Eckl, 2015). Physical 
activity promotes specific adaptations in relation 
to type and intensity of exercise performed, to 
defend the body from an excessive ROS production, 
improving motor performance (Castrogiovanni and 
Imbesi, 2012). Aerobic and regular training exerts 
beneficial effects decreasing oxidative damage and 
up-regulating antioxidant pathways (Allen et al. 
2008, Falone et al., 2010; Farinha et al., 2015). So, 
long term, regular and moderate exercise promotes a 
more reducing environment, while intensive exercise 
training leads to more oxidizing environment (Seifi-
Skishahr et al., 2016).
Besides sport with both aerobic and anaerobic 
components, such as volleyball, may provide 
adequate protection against exercise-induced 
oxidative stress (Kocabas¸ et al., 2016). Kocabas¸ 
and collaborators (2016) noted, in thirteen male 
volleyball players, that serum total oxidant status 
(TOS) levels and oxidative stress index (OSI) were 
significantly lower after volleyball match.
Physical activity in DMD and BMD
There are evidences from mdx mouse models 
that eccentric exercise can be more damaging to 
dystrophic muscle than to normal muscle (Ensrud 
and Kissel, 2015). Stretch-induced muscle damage 
is considerably more severe in the mdx mouse and 
transfection of dystrophin into mdx muscle causes 
a reduction of the damage. Furthermore, eccentric 
exercise causes a substantial increase in muscle Ca2+ 
which accumulates in the mitochondria resulting 
in activation of PLA2 and ROS production that 
increases lipid peroxidation and changes membrane 
permeability in mdx mouse (Allen et al., 2008). 
Schill et al. (2016) have been tested in mdx mice, 
with respect to sedentary mdx and wild-type mice, if 
a forced treadmill exercise program (twice-weekly, 
for 4 weeks) influences oxidative stress and exercise 
capacity. They observed a lower exercise capacity 
in sedentary mdx versus wild-type mice. After the 
exercise program, mdx mice showed lower basal 
oxygen consumption and exercise capacity, but a 
similar maximal oxygen consumption with respect 
to wild-type mice. The clinical signs of pathology 
were increased by raising limb muscle damage 
and reducing exercise capacity. In addition, the 
skeletal muscles from trained mdx mice displayed 
an increase of oxidative stress with higher amounts 
of oxidized GSH and hydroxyproline, with respect 
to mdx sedentary mice.
In contrast, several evidences show that moderate and 
low intensity training (LIT) can decrease onset of motor 
deficits compared with minimal and excessive activity 
(Ensrud and Kissel, 2015). Comparing the effect of 
LIT (carried out by a motorized treadmill) on oxidative 
stress biomarkers in skeletal muscle from mdx and 
wild-type mice, Kackzor and coworkers (2007) found 
higher MDA levels in white muscle from sedentary 
mdx mice versus sedentary and LIT wild-type groups; 
protein carbonyl content was higher in white and 
red muscle of mdx with respect to wild-type mice. 
However, antioxidant SOD, CAT and GPX activities 
were higher in white muscle of mdx than in wild-type 
mice. After LIT, white muscle of mdx mice showed 
lower MDA and protein carbonyl levels and it did 
not enhanced antioxidant activity of tested enzymes. 
Subsequently, these results have been confirmed by 
two independent working groups (Fontana et al., 2015; 
Hyzewicz et al., 2015). In the first report, Fontana et 
al. (2015) shown a significant recovery of damaged 
skeletal muscle of mdx mouse following LIT (30 days). 
In this study, however, protein levels of SOD1 were 
down-regulated while carbonic anhydrase 3 levels 
(a member of the zinc metalloenzymes family) were 
up-regulated in quadriceps of sedentary mdx mice. 
In addition, in exercised mdx mice both values were 
significantly restored to the values of sedentary and 
exercised wild-type mice. Hyzevicz and collaborators 
(2015) found that LIT (swim training: 30 min/day, for 
4 days/week, for one month) induced a reduction of 
protein carbonyls and an increase in the expression 
of proteins involved in mitochondria function, muscle 
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contraction, glycogen metabolism, and glycolysis. 
Interestingly, the authors also noted that the beneficial 
effects of LIT were more pronounced in mdx than in 
wild-type muscle. In particular, while in mdx muscle, 
exercise reduced protein carbonyls levels and increased 
their expression, in wild-type mice LIT increased 
protein carbonylation but had limited influence on 
their expression. In a human randomized controlled 
trial, thirty boys with DMD were recruited and divided 
into two groups: intervention and control group. The 
first group was subjected to training of the legs (by 
bicycle) and arms during 24 weeks, five times per 
week. The second group received the same treatment 
after a waiting period of 24 weeks. The training was 
feasible and safe for both ambulant and wheelchair-
dependent children. It has been demonstrated that 
the interventions improved muscle strength in half of 
the patients evaluated by manual muscle testing and 
delayed functional deterioration (Jansen et al., 2013).
Another study that investigated in adult patients with 
BMD the effect of aerobic and moderate-intensity 
training, concluded that it was an effective and safe 
method to increase fitness. These beneficial effects 
were experienced both after 12 weeks and 1 year of 
training highlighting the importance of rehabilitation 
exercises in this patients (Sven et al., 2008).
These results are important for introduce therapeutic 
exercise in patients with MyD in which exercise 
prescription remains under discussion (Hyzewicz et 
al., 2015).
Physical activity in FSHD
Even in FSHD aerobic exercise appears to be safe and 
potentially beneficial improving exercise performance 
(Olsen et al., 2005). Andersen et al. (2015) assessed 
the effect of regular aerobic training (36 sessions 
of 30 minute of cycle-ergometer training, for 12 
weeks) in FSHD patients on fitness, walking speed, 
muscle strength, and daily activity levels. The authors 
observed that fitness, workload, physical capacity, 
walking speed, and health improved (10%, 18%, 7%, 
respectively), while muscle strength and daily activity 
levels did not change after the training session.
A randomized controlled trial was conducted 
to investigate the effects of a 24-week adapted 
home-based exercise training program in 19 FSHD 
patients (N=10 training group, N=9 control group, 
no-training) evaluating the safety and efficacy 
of combined aerobic, high-intensity interval 
and strength training on motor function, muscle 
histological, biochemical characteristics and quality 
of life. The training increased VO
2max
, maximal 
aerobic power, citrate synthase enzyme activity, 
muscle strength and endurance improved motor 
function (walking speed), and reduced experienced 
fatigue. The training intervention did not alter 
quality of life and muscle integrity (serum CK levels 
and muscle morphology). These findings suggested 
that combined training is a well-tolerated, safe, and 
effective long-term method to induce functional 
gains without muscle damage in FSHD patients 
(Bankolé et al., 2016).
Despite these evidence, another FSHD randomized 
controlled trial reported no aerobic power 
improvement after 16 weeks of aerobic training, 
though reduced chronic fatigue. This study was 
conducted on 28 FSHD patients and the aerobic 
training consisted of 3 weekly sessions of cycling 
exercise for 30 minutes (Voet et al., 2014).
Our preliminary and unpublished data on 8 FSHD 
patients affected by a mild-moderate form of disease 
show that an exercise protocol on cycle-ergometer 
evaluation (basal, 70% of maximal voluntary 
contraction and recovery) may be easily deployable 
and suitable for a proper clinical assessment of 
fatigue in patients. Data about oxidative stress do 
not shown significant differences in some analyzed 
oxidative stress biomarkers (AOPP, FRAP and 
total thiols) between patients and controls (N=8); 
the levels of oxidative stress biomarkers remained 
stable during and after the exercise protocol, both 
in patients and controls, even if we observed a 
reduction (not significant) of oxidative damage to 
proteins after exercise, in FSHD patients. However, 
only a few subjects were analyzed and a single 
bouts of exercise do not allow to evaluate significant 
changes in oxidative stress biomarkers. There is the 
need to increase the number of subjects for analysis 
and to test if oxidative parameters can be changed in 
response of exercise training.
Physical activity in LGMD
As reviewed by Siciliano and collaborators, several 
studies have shown that exercise can be safe and 
beneficial also for LGMD patients (Siciliano et al., 
2015). For example, Sveen et al. (2007) analyzed 
the effect of low intensity aerobic training in patients 
(N=9) with LGMD2I, caused by mutations in the 
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fukutin-related protein gene (FKRP). The training 
program consisted in 30 minute of training (fifty 
sessions) for 12 weeks on cycle-ergometer at 65% of 
VO
2max
. The different parameters were evaluated from 
24 to 48 hours after the final training session, after 
which VO
2max
 and maximal workload were improved. 
Plasma lactate levels during the different exercise test 
steps did not differ significantly before and after 12 
weeks of training and plasma CK levels increased 
after training in patients similarly to controls (N=9). 
Subsequently, the authors presented the results of 
two pilot studies on the effect of resistance training. 
In particular, in one study they assessed the effect of 
low-intensity strength training in LGMD2A (N=2), 
and LGMD2I (N=4) patients showing that elbow 
flexion and knee extension significantly increased 
muscle strength and endurance. In the second 
study, the authors investigated the effect of high-
intensity strength training in patients with LGMD2A 
(N=4), and LGMD2I (N=2). The preliminary results 
indicated that 3 months of resistance training could be 
beneficial increasing muscle strength and endurance 
in these patients (Sveen et al., 2013).
In another study, patients (N=6) with LGMD2L, also 
known as anoctaminopathy due to recessive ANO5 
gene mutations, were selected for test any effects 
of home-based, pulse-watch monitored, moderate-
intensity exercise on a cycle-ergometer (30 minutes, 
3 times weekly, for 10 weeks. Outcome measures 
were VO
2max
, performed at 70% of the VO
2max
, and 
time in the 5-repetitions-sit-to-stand test (FRSTST), 
requiring patients to stand up and sit from a chair 5 
times as rapidly as possible. The authors observed a 
significant improvement of the VO
2max
 and FRSTST, 
increased oxidative capacity and muscle function, 
no change in the CK levels and no detrimental 
effects (Vissing et al., 2014).
Physical activity in DM1
Aldehag et al. (2013) performed a randomized 
controlled trial with a crossover design to investigate 
the effects of a training program (12 weeks) on 
hand-grip, testing pinch and wrist force, manual 
dexterity and activities of daily living, in 35 adults 
with DM1. The authors observed that this type 
of training improved wrist flexor force as well as 
self-perception and satisfaction of performance. No 
evident detrimental effects were shown, suggesting 
that resistance training of hand muscles can be a 
good therapy option for the clinical practice in DM1 
patients.
Another study indicated that 12 weeks of low-
intensity, aerobic training on a cycle-ergometer was 
an effective and safe method to improve oxidative 
capacity and fitness in patients with DM1 (N=12). 
The training increased VO
2max
 by 14%, and maximal 
workload by 11%, whereas CK levels remained 
unchanged. Moreover, muscle fiber diameter for 
type I and IIa fibers increased significantly and self-
reported changes in activities of daily living improved 
during the training weeks (Orngreen et al., 2008).
Tramonti and coworkers (2014) evaluated the 
oxidative metabolism efficiency in 18 DM1 patients 
versus 15 healthy subjects, evaluating lactate levels 
at rest and after a submaximal incremental exercise 
test performed on a treadmill. The results showed, 
after exercise, an early induction of fatigue in patients 
compared to controls; moreover, patients detected 
normal lactate values at rest, which increased during 
recovery. These findings suggest an early induction 
of anaerobic metabolism with consequent alteration 
of oxidative metabolism in DM1. Considering that 
aerobic training improve muscle oxidative capacity 
and facilitates the lactate removal, it could be used 
to help DM1 patients with rehabilitation programs 
focused to limit muscle damage.
Conclusions
Despite the evidence that exercise increase the 
reactive species production, habitual and moderate 
physical activity reduces the incidence of many 
oxidative stress-based diseases and is advantageous 
also in patients with MDs. However, there is the 
need to conduct a systematic search to point out the 
effects of physical exercise in experimental settings. 
The identification of strategies for limiting the 
excess of ROS both in basal condition and during 
physical activity could be helpful to limit muscle 
damage and improve muscle function in MDs.
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